Exact Sciences

Exact Sciences is a leading molecular diagnostics company focused on the early detection and prevention of cancer. Established with a mission to save lives through innovative testing solutions, the company has developed a range of products that empower patients and healthcare providers alike.

At the core of Exact Sciences’ offerings is its flagship product, Cologuard, a non-invasive stool DNA test for colorectal cancer screening. This groundbreaking test has revolutionised the way colorectal cancer is detected, making it more accessible and convenient for patients.

In addition to Cologuard, Exact Sciences is committed to expanding its portfolio with advanced diagnostic tests for various types of cancer, including lung and prostate cancers. The company invests heavily in research and development to ensure that its tests are not only accurate but also user-friendly.

Exact Sciences operates with a vision to be the most trusted partner in cancer diagnostics, striving to improve patient outcomes through early detection. The company collaborates with healthcare professionals, researchers, and advocacy groups to raise awareness about the importance of regular screenings.

With a strong emphasis on quality and innovation, Exact Sciences adheres to the highest standards in laboratory practices and regulatory compliance. The company’s dedication to excellence is reflected in its numerous awards and recognitions within the healthcare industry.

Headquartered in the United States, Exact Sciences is expanding its reach globally, including efforts to establish a presence in the UK market. The company aims to provide UK patients with access to its cutting-edge diagnostic solutions, contributing to the fight against cancer on an international scale.

As part of its corporate responsibility, Exact Sciences is committed to community engagement and education, ensuring that individuals understand their health options and the significance of early cancer detection.

In summary, Exact Sciences is at the forefront of cancer diagnostics, driven by a passion for innovation and a commitment to saving lives. Through its advanced testing solutions, the company is making significant strides in the battle against cancer, one test at a time.